METRION PHARMA LTD

METRION PHARMA LTD is an active private limited company incorporated on 14 February 2018 and registered in England and Wales. Its registered office is at First Floor, Building 2 Granta Centre, Granta Park, Great Abington, Cambridge, CB21 6AL, United Kingdom. Its principal activity is other research and experimental development on natural sciences and engineering (SIC 72190).

It is controlled by Metrion Biosciences Ltd, which holds 75-100% of the shares and voting rights and has the right to appoint and remove directors. The board consists of two British directors: MCCULLAGH, Keith Graham, Dr (appointed 14 February 2018) and STEVENS, Edward Benedict, Dr (appointed 5 April 2018). RUTTY, Clare Louise serves as company secretary (appointed 11 June 2019). The company has been served by three former officers who have since resigned.

The company has no charges, no insolvency history and has never been liquidated. The company filed its most recent dormant accounts, covering the period to 31 December 2025, on 21 June 2026. The next accounts are due by 30 September 2027. Its most recent confirmation statement was made up to 12 February 2026. The next is due by 26 February 2027. 29 filings are recorded against the company at Companies House, most recently an accounts filing on 21 June 2026.